Indications
Therapeutic Asset Ratings
13,150 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Entinostat
Lymphoma
National Cancer Institute (NCI)
P2
CCC
(55)
Eribulin
Ovarian Cancer
Second Affiliated Hospital of Guangzhou Medical University
P2
CCC
(55)
Eribulin/Farletuzumab Antibody Drug Conjugate
Ovarian Neoplasm
Bristol-Myers Squibb
P2
CCC
(55)
ETD001
Cystic Fibrosis
Enterprise Therapeutics Ltd
P2
CCC
(55)
Etoposide
Ovarian Carcinoma
Fudan University
P2
CCC
(55)
Etoposide
Plasma Cell Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
P2
CCC
(55)
Eudemine Injection
Obesity Disorder
Columbia University
P2
CCC
(55)
Exemestane
HER2 Positive Breast Carcinoma
Fudan University
P2
CCC
(55)
Ezabenlimab
Neoplasm
Boehringer Ingelheim
P2
CCC
(55)
Fenofibrate
Breast Carcinoma
Tanta University
P2
CCC
(55)
Fenofibrate
Metabolic Dysfunction-Associated Steatotic Liver Disease
Yokohama City University
P2
CCC
(55)
Fepixnebart
Diabetic Neuropathy
Eli Lilly and Company
P2
CCC
(55)
Fexagratinib
Lymphoma
National Cancer Institute (NCI)
P2
CCC
(55)
Flortaucipir
Cognitive Disorder
University of Pennsylvania
P2
CCC
(55)
Flortaucipir
Traumatic Brain Injury
University of North Carolina, Chapel Hill
P2
CCC
(55)
Fludarabine
Adenocarcinoma
M.D. Anderson Cancer Center
P2
CCC
(55)
Fludarabine
Breast Carcinoma
Essen Biotech
P2
CCC
(55)
Fludarabine
Chronic Leukemia
Roswell Park Cancer Institute
P2
CCC
(55)
Fludarabine
Inborn Error Of Immunity
Paul Szabolcs
P2
CCC
(55)
Fludarabine
GATA2 Deficiency With Susceptibility To MDS/AML
Fred Hutchinson Cancer Center
P2
CCC
(55)
Fludarabine
SAMD9L-Related Spectrum And Myeloid Neoplasm Risk
Fred Hutchinson Cancer Center
P2
CCC
(55)
Fludarabine
SAMD9-Related Spectrum And Myeloid Neoplasm Risk
Fred Hutchinson Cancer Center
P2
CCC
(55)
Fludarabine
Inherited Sideroblastic Anemia
Fred Hutchinson Cancer Center
P2
CCC
(55)
Fludarabine
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Patrick C. Johnson, MD
P2
CCC
(55)
Fludarabine
Langerhans Cell Histiocytosis
M.D. Anderson Cancer Center
P2
CCC
(55)
Showing 2751 to 2775 of 13,150 assets
Previous
Page 111 of 526
Next